Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M116Revenue (TTM) $M13.4Net Margin (%)-445.3Altman Z-Score-3.4
Enterprise Value $M31.3EPS (TTM) $-0.9Operating Margin %-463.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score42.3Pre-tax Margin (%)-445.3Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %-19.3Quick Ratio3.3Cash flow > EarningsY
Price/Sales8.55-y EBITDA Growth Rate %-0.6Current Ratio3.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-51.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-70.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M74.8ROIC % (ttm)-612.8Gross Margin Increase y-yN

Gurus Latest Trades with ARWR

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARWR is held by these investors:



ARWR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GIVEN DOUGLAS BDirector 2016-10-14Sell12,000$6.72-76.93view
Myszkowski Kenneth AllenCFO 2016-08-23Sell20,000$8-80.63view
Myszkowski Kenneth AllenCFO 2016-08-23Sell20,000$8-80.63view
Myszkowski Kenneth AllenCFO 2015-12-30Sell23,347$6.13-74.71view
Lewis David L.Chief Scientific Officer 2015-01-05Sell15,000$8.01-80.65view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.32-75.47view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.32-75.47view
McKenney CharlesDirector 2014-10-01Sell2,500$14.7-89.46view
Lewis David L.Chief Scientific Officer 2014-09-30Sell15,000$15.02-89.68view
GIVEN DOUGLAS BDirector 2014-09-26Sell2,000$15.24-89.83view

Quarterly/Annual Reports about ARWR:

News about ARWR:

Articles On GuruFocus.com
Arrowhead Research Making Headway In The RNAi Therapy Platform Mar 09 2015 
Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR Oct 20 2014 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 10 2011 
Weekly CFO Buys Highlight: JAZZ, VRTB, ASTM, ARWR, CGX Sep 04 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 13 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 11 2010 
Arrowhead Research Corp. Reports Operating Results (10-K) Dec 22 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Aug 10 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 15 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 09 2009 

More From Other Websites
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) Jun 09 2017
ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : May 26, 2017 May 26 2017
Edited Transcript of ARWR earnings conference call or presentation 3-May-17 8:30pm GMT May 06 2017
Arrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q2, 2017 By the Numbers : May 5, 2017 May 05 2017
Today's Research Reports on Arrowhead Pharmaceuticals and Paratek Pharmaceuticals Post Earnings May 05 2017
Arrowhead Reports Fiscal 2017 Second Quarter Results May 03 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results Apr 26 2017
Arrowhead Pharmaceuticals Presents ARC-AAT Clinical Data at The International Liver Congress™ Apr 24 2017
Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress™ Apr 20 2017
ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : April 19, 2017 Apr 19 2017
Arrowhead Pharmaceuticals Announces Presentations at The International Liver Congress™ Apr 05 2017
ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : March 27, 2017 Mar 27 2017
Arrowhead Pharmaceuticals Adopts Stockholder Rights Agreement Mar 23 2017
Arrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q1, 2017 By the Numbers : March 21,... Mar 21 2017
SBPH: 2016 Results Sustaining Continued HBV/STING Development Feb 27 2017
These 5 Stocks Under $10 Could Explode Higher Feb 16 2017
Edited Transcript of ARWR earnings conference call or presentation 6-Feb-17 9:30pm GMT Feb 06 2017
Arrowhead Research reports 1Q loss Feb 06 2017
Arrowhead Reports Fiscal 2017 First Quarter Results Feb 06 2017
Drug Approvals Expected to Rise as Trump Pledges to Speed Up Approval Process: Latest Reports on... Feb 01 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}